Dianthus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 8, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,872	645	154	-	-
Market Cap Growth	204.45%	318.69%	-	-	-
Enterprise Value	1,315	364	-35	-	-
Last Close Price	43.60	21.80	10.40	-	-
PS Ratio	607.34	103.48	54.53	-	-
PB Ratio	3.42	1.83	0.91	-	-
P/TBV Ratio	3.42	1.83	0.91	-	-
EV/Sales Ratio	427.29	58.45	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.01	-
Asset Turnover	0.01	0.02	0.02	0.14	-
Quick Ratio	17.09	14.96	18.09	9.86	1.70
Current Ratio	17.35	15.22	18.43	9.97	1.75
Return on Equity (ROE)	-28.57%	-32.60%	-35.92%	-73.25%	-
Return on Assets (ROA)	-18.82%	-23.01%	-22.94%	-40.12%	-
Return on Capital (ROIC)	-19.80%	-24.33%	-24.69%	-47.27%	-
Return on Capital Employed (ROCE)	-25.30%	-28.60%	-28.40%	-39.70%	-319.20%
Earnings Yield	-6.76%	-13.17%	-28.26%	-	-
FCF Yield	-5.86%	-12.13%	-23.99%	-	-
Buyback Yield / Dilution	-28.44%	-546.44%	-489.48%	78.17%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q